Stock Information
Abcellera Biologics Inc (ABCL)
Ticker Symbol: ABCL
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $1,053.66 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.4904
Revenue (TTM): $0.25 M
Dividend Yield: N/A%
ROE: -14.79%
Latest News
-
AbCellera to Present at Upcoming Investor Conferences in May and June 2026
Thu, May 7, 2026 4:10 PM
-
Cantor Fitzgerald Initiates Coverage On AbCellera Biologics with Overweight Rating, Announces Price Target of $7
Tue, May 5, 2026 1:45 PM
Key Financials
Financial data not available
